title: Ciprofloxacin breakpoints in enteric fever--time to revise our susceptibility criteria.
authors.forename: C
authors.initials: C
authors.lastname: Rodrigues
authors.forename: N Jai
authors.initials: NJ
authors.lastname: Kumar
authors.forename: J
authors.initials: J
authors.lastname: Lalwani
authors.forename: A
authors.initials: A
authors.lastname: Mehta
mesh_terms: D002939:Ciprofloxacin / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D007194:India; D008826:Microbial Sensitivity Tests; D010284:Paratyphoid Fever / Q000188:drug therapy / Q000382:microbiology*; D012482:Salmonella paratyphi A / Q000187:drug effects*; D012485:Salmonella typhi / Q000187:drug effects*; D014435:Typhoid Fever / Q000188:drug therapy / Q000382:microbiology*
chemical_list: D002939:Ciprofloxacin